Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
American Journal of Hypertension|August 6, 2002
Effect of estrogen receptor modulator tamoxifen on blood pressure, plasma renin activity, and renal sodium excretionGeorge S Stergiou, Andromachi S Zourbaki, Stamatis P Efstathiou, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 15, 2012
Topotecan and pegylated liposomal doxorubicin combination as palliative treatment in patients with pretreated advanced malignant pleural mesotheliomaDimitrios T Trafalis, Constantinos Alifieris, Dimitrios Krikelis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancerGeorge P Stathopoulos, Sotiris K Rigatos, Nikos Pergantas, et al.
Anticancer Research|May 23, 2002
Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental studySotiris K Rigatos, George P Stathopoulos, Ismene Dontas, et al.
Oncology Reports|July 7, 2009
Survival after cytotoxic chemotherapy in patients with advanced hormone-resistant prostate cancer: a phase II studyGeorge P Stathopoulos, John Koutantos, Michael M Vaslamatzis, et al.
Oncology Reports|March 10, 2005
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I studyGeorge P Stathopoulos, Teni Boulikas, Maria Vougiouka, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2004
Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II studyGeorge P Stathopoulos, Sotiris K Rigatos, Christos Christodoulou, et al.
Cancer Investigation|March 23, 2005
Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II studyNikolaos Androulakis, Konstantinos Syrigos, Aristidis Polyzos, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2006
Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancerDimosthenis Antoniou, Georgia Pavlakou, George P Stathopoulos, et al.
Anti-Cancer Drugs|June 21, 2014
The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypesGeorge P Stathopoulos, Nikolaos A Malamos, Christos Markopoulos, et al.
Pageof 5